Directed evolution is a powerful tool to improve the characteristics of biomolecules. Here we present a protocol for the intracellular evolution of proteins with distinct differences and advantages in comparison with established techniques. these include the ability to select for a particular function from a library of protein variants inside cells, minimizing undesired coevolution and propagation of nonfunctional library members, as well as allowing positive and negative selection logics using basally active promoters. a typical evolution experiment comprises the following stages: (i) preparation of a combinatorial M13 phagemid (pM) library expressing variants of the gene of interest (GoI) and preparation of the Escherichia coli host cells; (ii) multiple rounds of an intracellular selection process toward a desired activity; and (iii) the characterization of the evolved target proteins. the system has been developed for the selection of new orthogonal transcription factors (tFs) but is capable of evolving any gene-or gene circuit function-that can be linked to conditional M13 phage replication. Here we demonstrate our approach using as an example the directed evolution of the bacteriophage l cI tF against two synthetic bidirectional promoters. the evolved tF variants enable simultaneous activation and repression against their engineered promoters and do not cross-react with the wild-type promoter, thus ensuring orthogonality. this protocol requires no special equipment, allowing synthetic biologists and general users to evolve improved biomolecules within ~7 weeks.
IntroDuctIon
Directed evolution has emerged as a powerful tool to improve the characteristics of biomolecules [1] [2] [3] . The approach mimics natural selection to evolve biomolecules toward a desired activity 4 . One efficient and commonly used strategy to achieve this in a laboratory environment is to use filamentous bacteriophages such as M13 to link a mutable genotype to a selectable phenotype. In this way, a number of M13-phage-assisted methods, such as the widely used phage display technology 5 , have been developed and applied to improve a wide variety of proteins, including antibodies [6] [7] [8] , DNA-binding proteins 9, 10 and enzymes 11, 12 . These systems are characterized by an extracellular (in vitro) or intracellular (in vivo) mode of operation. In vitro systems are generally easier to engineer in terms of selection stringency adjustments 13 , but possess certain limitations that can only be overcome by applying intracellular processes. For example, selection from combinatorial libraries in vivo ensures compatibility with the host cell machinery. This facilitates the optimization of synthetic proteins and gene circuits [14] [15] [16] , which ultimately have to function in a host cell context. In vivo methods promote selection for orthogonality 17, 18 -a lack of cross-reactions-by intrinsically counterselecting against adverse effects inside the cell. To further broaden the applications of in vivo directed evolution, we recently developed an M13-phage-based method 19 for the intracellular selection of proteins from combinatorial libraries with distinct differences and advantages to established techniques.
Overview of the protocol
This protocol describes a general approach for the directed evolution of proteins from combinatorial libraries on PMs (Fig. 1) . The selection process takes place inside E. coli cells by linking the target protein's activity to conditional phage production, thus allowing enrichment of functional library members. This is exemplified here by the directed evolution of orthogonal dual TFs based on bacteriophage λ cI variants 19 , selecting against synthetic promoters. However, the method can be readily adapted for other target biomolecules ("Applications of the method"). A typical evolution experiment consists of the following: (i) the preparation of a combinatorial M13 phage library (Steps 1-38) and E. coli host cells (Steps 39-47); (ii) the selection process toward a desired activity (Steps 48-61); and (iii) the characterization of the selected target proteins (Steps 62-68) (Fig. 2) .
The system is based on E. coli cultures and three compatible plasmids (available from Addgene; see MATERIALS). Together, these conditionally produce phage (containing the evolving gene) in correlation to the activity of a library member. A selection experiment always begins with an E. coli culture that contains the first two plasmids: a modified helper phage plasmid (HP) and an accessory plasmid (AP) (Fig. 3a) . The HP provides almost all that is needed for phage propagation, except for two essential genes (gIII and gVI). Furthermore, the weak M13 packaging signal (PS) is removed from the original M13KO7 HP to obtain the final M13KO7-∆PS-∆gIII-∆gVI HP. The second plasmid, AP, contains a conditional gene circuit that links an inducible input (e.g., a promoter with a novel operator) to gVI expression. The evolving gene or gene circuit is placed on the third plasmid, termed a PM, which is packaged into an infectious phage particle only when all phage genes are expressed. The PM contains the second missing gene (gIII) and a combinatorially randomized GOI and is provided to the E. coli culture in the form of an infectious phage library (Fig. 3b) . Crucially, our system moves Gene III onto the PM so that phage replication occurs only after initial infection, thus circumventing infection resistance 20, 21 and decreasing Intracellular directed evolution of proteins from combinatorial libraries based on conditional phage replication the chances of propagating nonfunctional library members because of multiple infections. A GOI with the desired characteristics upregulates gene VI expression on the AP, completing the phage life cycle. For example, a randomized TF library member that activates an artificial promoter upstream of gVI will increase its own phage production (Fig. 4a) . In this way, a protein with novel desired properties can be selected after several rounds of reinfection.
Applications of the method
The method has been used to evolve a set of dual activator-repressor switches for orthogonal logic gates, based on bacteriophage λ cI variants, and multi-input promoter architectures, and these switches have been successfully applied in downstream synthetic gene circuits 19 . In general, the method is capable of evolving any gene-or gene circuit function-on the PM that can be linked to pVI production. This is analogous to previous uses of phageassisted continuous evolution (PACE) 22 (Fig. 4) . With PACE, a wide range of medically and biotechnologically relevant biomolecules, including polymerases 22 , proteases 23 and genome-editing proteins 10 , as well as protein-protein interactions 24 , were linked to conditional M13 phage propagation. In principle, any application in which directed evolution approaches have been proposed (e.g., biosensors 25 or hybrids with chemical evolution 26 ) can be adapted to this method if the target protein's activity can be linked to conditional M13 phage production. However, certain applications (e.g., those involving membrane proteins) would be harder to adapt, which is why other methods such as liposome display 27 have been developed.
Comparison with other methods
Several bacterial directed evolution methods have been developed based on phage replication 22 , display technologies 5,27-29 , genome engineering 30 , and conditional cell growth 31, 32 . Linking a target protein's activity to cell growth is a widely used strategy and is particularly suitable when the evolving gene directly improves cellular fitness 33, 34 . The use of bacteriophage offers a convenient way to uncouple the fitness function of a cell with target protein activity. This is achieved by linking a target gene's activity to phage replication using a conditional gene circuit. The main advantage of conditional phage production over display technologies is the compatibility of target genes or gene circuits with the host cell machinery, as these have to function in a host cell context. In contrast to PACE (which uses gIII as the sole conditional gene), our PM-based approach facilitates the selection of large combinatorial libraries and enables positive and negative selection logics using promoters with basal gene expression. Our system also minimizes the undesired coevolution of phage genes, as only the packaged PM is evolving and not the HP itself. In comparison with PACE, the protocol is performed in batch mode and therefore requires no special equipment for reactor assembly, instead relying on daily researcher intervention during selections. Moreover, the batch process facilitates the performance of multiple selections in parallel, enabling the scalability of each individual selection and easy handling. Continuous culture evolution systems can suffer from 'phage washout' (loss of phage) when conditional phage production rates are not compatible with the flow rates. By contrast, batch modes are not as sensitive to loss of phage. On the other hand, dozens of rounds of reinfections occur in a single day of PACE, whereas our system is currently limited to one round per overnight cycle. In addition, combinatorial libraries have to be designed and cloned because, unlike PACE, our system does (1) Phagemid library generation: a combinatorial DNA library is generated from the target gene on a phagemid (PM) that also contains conditionally expressed M13 gene III and the M13 packaging signal. The DNA library members are then packaged into phage particles, which are the starting point for selection. (2) Selection cycles: TG1 cells containing a modified helper phage (HP) and an accessory plasmid (AP) are infected with the constructed phage library. The HP provides all that is required for phage propagation, except for two essential genes (gIII and gVI). The AP contains a conditional gene circuit that links the target protein's activity to conditional phage production (gene VI expression). Enrichment for a particular protein function occurs after several rounds of selection. (3) Gene isolation: cells are infected with selected phages, and the phagemid DNA is amplified and purified. (4) Protein characterization: the target protein's activity needs to be analyzed with a suitable reporter assay. not include a random mutagenesis plasmid 35 . This means that structural information or a partial understanding of how a set of amino acid changes will affect the target protein's activity is required to run our system.
Limitations of the phagemid-based system
The main limitation of the system is the combinatorial size of the library, which is linked to transformation efficiency (10 6 -10 10 variants) 36 . The selection process itself is not limited to a certain number of gene variants, but it has to be noted that the use of larger libraries comes with the cost of prolonged experiment times. Another limitation can be the linkage of the target protein's activity to conditional M13 phage replication, as this depends on the individual protein's characteristics. This is certainly more complicated for complex proteins such as membrane proteins than it is for cytosolic proteins. Furthermore, general limitations of bacterial expression over mammalian expression (e.g., protein solubility, disulfide bonds, post-translational modifications) need to be considered for individual target proteins. For instance, our system would need to be adapted to enable the selection of proteins that require disulfide bonds for proper folding in bacterial cells 37 .
Experimental design
Combinatorial library cloning on phagemid. Choosing which positions to randomize in the protein of interest is a critical step, as this affects the library size, the cloning strategy and ultimately the overall selection results. Small libraries with only one or two randomized positions can easily be obtained by round-the-world PCR, whereas bigger libraries require overlap extension PCR or end-to-end ligation 36 . Round-the-world PCR means, in this context, that single-base-pair mutations are inserted into the target region by amplification of the whole plasmid DNA with randomized primers so that no additional step for plasmid ligation is required. For round-the-world PCR, both randomized primers must contain the mutations and bind to the same DNA sequence on opposite strands of the plasmid. Primers are generally 30-60 nucleotides long (N) and contain mutations in the middle of the randomized primers, flanked with 15-20 bases of correct sequence on both sides. These primers should ideally have a minimum GC content of 40% (%GC), end with one or more C or G bases and are purified by PAGE. The annealing region should have a melting temperature (T m ) of ≥78 °C, as determined via the following formula: T m = 81.5 + 0.41(%GC) -675/N -%mismatch. In this protocol, we focus on an overlap PCR approach before Gibson assembly 38 , as this has been our method of choice for building λ cI opt libraries with a combinatorial space of >10 6 variants (Fig. 5a ). These libraries are based on a λ cI optimized mutant (cI opt ) with a strong activation region 39 . The protocol presented here is optimized for the construction of combinatorial libraries by Gibson assembly. It is our method of choice because it bypasses the need for restriction sites inside target genes, which makes it much easier to construct sequence-targeted libraries. However, the selection system itself is compatible with any other library generation method 36, 40 as long as our PM vector backbone is used. The design of randomized oligonucleotides for overlap PCR is similar to conventional Gibson primer design 38 , and the RNA polymerase ω subunit (RpoZ; yellow) is fused to the evolving protein (red). Target protein binding of the evolving protein 24 enables the localization of RNA polymerase upstream of gene VI, initiating gene expression from the P lacZ-opt promoter. (e) The T7 polymerase (gray) is inhibited when bound to T7 lysozyme (dark blue), as it inhibits transcription initiation and the transition from initiation to elongation 44 . Proteolysis of the target cleavage site (red) by an evolving protease 23 activates the T7 RNA polymerase, enabling gene VI expression downstream of the T7 promoter. Gene VI is annotated with an asterisk where originally conditional gene III was used instead of gene VI with PACE 10, [22] [23] [24] . Gene III and gene VI are both minor coat proteins, each present in three to five copies per phage particle 21 .
T m = 4(G + C) + 2(A + T) (where A, C, G and T are the numbers of each base in the primer). The temperature difference of the primer pairs should be matched and lie within a 5 °C range. The maximum insert size is limited by oligonucleotide synthesis (currently ~120 bp; desalted oligonucleotides are sufficiently pure). To evolve a novel protein, the user should ideally start with a crystal structure of the target molecule (if available) and randomize positions known to affect the desired activity (e.g., change positions of the binding interface to alter the protein binding interaction). In other cases, biochemical information might also be sufficient to guide library construction. Accessory plasmid design. The conditional gene circuit that links an inducible input to gVI expression has to be adapted to individual needs. This is achieved by replacement of the λ P RM promoter (pJPC12-∆PS-P RM -B0034-gVI) with a different promoter or inducible input depending on the desired application (Fig. 5b) . The bidirectional promoter P R /P RM consists of three operator sites (O1, O2 and O3), where λ cI binding to O1-O2 leads to P RM activation 41 . Counterselection via repression is achieved by placement of a specific DNA sequence at operator position O3, which is located between the −35 and −10 regions. For example, the O3 site of the P RM promoter can be replaced with the consensus wild-type (WT) sequence, O CS . Thus, binding of a cI opt library member to O1-O2 of an engineered P M promoter activates gene VI expression (and so promotes selection), whereas simultaneous binding to WT O3 represses gene VI, enabling counterselection against unwanted WT activity. We chose positive and negative selections against the synthetic promoters P M,5G6G and P M,5T6T as examples for this protocol (Supplementary Fig. 1 ). The engineered promoters are designated according to the positions of the base substitutions in the consensus half-site of O1 and O2. Reporter plasmid design. This protocol describes the downstream functional characterization of evolved TFs by fluorescence analysis. It has to be noted that a suitable reporter assay needs to be adapted to the target protein's properties according to the user's needs. For this, the bidirectional P R /P RM promoter on the reporter plasmid (RP) (pJPC12-∆PS-mCherry-P R /P RM -GFP) has to be replaced by the same inducible input used on the AP for selection (Fig. 5c) . The insertion of the bidirectional promoters P/P M,5G6G and P/P M,5T6T into the RP is depicted as an example for this protocol (Supplementary Fig. 2 ). For other target proteins, it might be sufficient to use one of the two reporters to analyze the activity of the selected proteins. Control selections. Enrichment assays can be performed to test the efficiency of the selection process. Mix plasmids containing λ cI opt (Addgene plasmid ID 80852) and one of the orthogonal cI variants (e.g., cI 5G6G,P ; Addgene plasmid ID 80861) in different ratios (e.g., 10 −3 and 10 −6 ). Then transform these into TOP10 cells with the modified HP M13KO7-∆PS-∆geneIII-∆geneVI and the AP pJPC12-∆PS-P RM -B0034-geneVI. This will allow the production of a phage stock packaged with cI opt and cI 5G6G,P (Steps 23-38). Use the obtained phage population and run a batch selection using the AP pJPC12-∆PS-P RM -B0034-geneVI (Steps 41-61). One can monitor the enrichment of λ cI opt by infecting TG1 cells (containing the plasmid pJPC12-∆PS-mCherry-P R /P RM -GFP; Addgene plasmid ID 80859) with the phage titer obtained after each round of selection. Streak out infected cells on agar plates supplemented with chloramphenicol and ampicillin and grow them overnight at 37 °C. The next day, analyze the plates under the UV light of a gel documentation system. The ratio of green to red colonies should increase over time because the nonactive TF cI 5G6G,P results in red colonies, whereas the enriched active cI opt leads to green colonies because of GFP activation and mCherry repression. As an alternative control selection, one can replace the TF cI 5G6G,P with a reporter (e.g., a red fluorescent protein (RFP)) on the PM and then monitor the selection process by infecting TG1 cells and counting the ratio of red to white colonies after each round of selection 19 . 
MaterIals

REAGENTS Cloning and plasmid construction
Plasmids: M13KO7-∆PS-∆geneIII-∆geneVI (Addgene plasmid ID 80840), pLITMUS-rpoN-cI opt -J23106-geneIII (Addgene plasmid ID 80852), pJPC12-∆PS-P RM -B0034-geneVI (Addgene plasmid ID 80858); optional: pJPC12-∆PS-mCherry-P R /P RM -GFP (Addgene plasmid ID 80859), pLIT-MUS-rpoN-cI 5G6G,P -J23106-geneIII (Addgene plasmid ID 80861) (Supplementary Fig. 3, Supplementary Table 1) . Sequences of all plasmids are listed in Supplementary Data Sets 1-5.
• Oligonucleotides (Sigma). Primers used for cloning are listed in Supplementary Research pipettes: 10 µl, 100 µl and 1,000 µl (Sigma, cat. no. Z683884) Tips: 10 µl, 200 µl and 1,000 µl (Starlab, cat. nos. S1111-3700-C, S1113-1700-C and S1111-6701-C) REAGENT SETUP Antibiotic stocks Prepare 100 mg ml −1 ampicillin in H 2 O (sterile filtered), 100 mg ml −1 kanamycin in H 2 O (sterile filtered) and 100 mg ml −1 chloramphenicol in ethanol. Prepare aliquots in sterile 1.5-ml tubes and store them at −20 °C for up to 6 months. The final concentrations, if not stated otherwise, are (1:1,000) , 50 µg ml −1 kanamycin (1:2,000) and 25 µg ml − for the amplification of the PM vector backbone (pLITMUS-rpoN-cI opt -J23106-geneIII) upstream of cI opt and downstream of the terminator BBa_B0015. Note that the terminator BBa_B0015 occurs twice in the parental plasmid. The 'medium strength' rpoN promoter is used to express the evolving gene to achieve a balance between functional expression and any potential metabolic load. The levels of the expressed target gene may need to be adjusted to the function in other cases.
2|
Design and order user-specific primers (e.g., cI-F and cI-R; supplementary table 2) for the GOI plus a terminator of choice (e.g., BBa_B0015) with a 15-to 25-bp overlap with the PM vector backbone.
3|
Amplify the GOI and vector backbone by PCR (Equipment Setup) and purify the samples using the QIAquick PCR purification kit.  crItIcal step If the PCR reactions contain unwanted by-products, gel extraction should be performed throughout the protocol with the QIAquick gel extraction kit. Use a DNA polymerase with proofreading activity (e.g., KOD DNA polymerase) for all PCR reactions throughout the protocol. 
7|
Incubate the cells for 1 h at 37 °C at 220 r.p.m. (SI500 incubator) and spread them onto LB plates supplemented with 100 µg ml −1 ampicillin.
8|
Allow the cells to grow overnight at 37 °C.
9|
The next day, pick single colonies and grow them in 5 ml of 2× TY supplemented with 100 µg ml −1 ampicillin overnight at 37 °C and 220 r.p.m. (SI500 incubator).
10|
Extract the PM DNA (QIAprep Spin miniprep kit) according to the manufacturer's instructions and confirm the nucleotide sequences by DNA sequencing using the primers pLITMUS-F and pLITMUS-R (table 1) .  pause poInt The extracted PM DNA can be stored at -20 °C for several years. 12| Amplify the PCR fragments (Equipment Setup) and purify the samples using the QIAquick PCR purification kit or the MinElute PCR purification kit (for samples <100 bp).  crItIcal step The PCR product concentration affects the efficiency of the assembly reaction. Optimized cloning efficiency requires at least 20 ng µl −1 of the PM vector backbone.
13| Add 1 µl of DpnI per 50-µl PCR reaction product and incubate for 1-2 h at 37 °C and 400 r.p.m.
(Thermomixer Compact).
15|
Pool the Gibson reactions, purify the assembled plasmid using the QIAquick PCR purification kit and elute in 30 µl of H 2 O.  crItIcal step Note that purification is important to decrease the salt concentration and to decrease the Gibson reaction components, as these are toxic to the cells at high concentrations.
16|
Measure the plasmid concentration with a spectrophotometer (NanoDrop Lite).  crItIcal step DNA concentrations should be >10 ng µl −1 for high transformation efficiency.  pause poInt The assembled plasmid can be stored at -20 °C for several years.
17| Transform 1-2 µl of DNA into 50 µl of electrocompetent cells (DH5-α or TG1) and add 950 µl of SOC medium.  crItIcal step Use electroporation as the method of choice for transformation, as it allows much larger library sizes.
18|
Incubate for 1 h at 37 °C at 220 r.p.m. (SI500 incubator).
19|
Plate the transformation reaction on Nunc Square BioAssay dishes (24.1 × 24.1 cm) supplemented with 100 µg ml −1 ampicillin and incubate overnight at 37 °C.
20|
The next day, harvest the cells with a cell spreader.  crItIcal step Only use plates with more than 10 5 clones. Estimate the transformation efficiency by plating serial dilutions (10 −2 and 10 −4 in 2× TY) on additional Petri dishes (57 cm 2 ) supplemented with 100 µg ml −1 ampicillin and counting the colonies the following day. Ideally, to cover the whole library space, at least a threefold excess of colonies relative to the theoretical library size is desired. ? trouBlesHootInG
21|
Purify the combinatorial DNA library using the HiSpeed Plasmid Maxi kit and elute in 0.5 ml of TE buffer. Measure the plasmid concentration with a spectrophotometer (NanoDrop Lite). The obtained plasmid concentration should ideally be >50 ng ml −1 .
22| Pick individual colonies (10-100 clones of a library depending on the library size and quality control desired) from the Petri dishes, which were used to estimate the transformation efficiency (Step 20), and culture each in 5 ml of 2× TY supplemented with 100 µg ml −1 ampicillin overnight at 37 °C at 220 r.p.m. (SI500 incubator). The next day, extract PM DNA (QIAprep Spin miniprep kit) and sequence the GOI using the primers pLITMUS-F and/or pLITMUS-R to confirm library diversity (table 1) .
? trouBlesHootInG  pause poInt The extracted PM DNA can be stored at -20 °C for several years.
production of M13 phage from a combinatorial phagemid library • tIMInG 1 week 23| Transform 50 µl of chemically competent Top10 cells with equal mole amounts of HP (M13KO7-∆PS-∆geneIII-∆geneVI) and AP (pJPC12-∆PS-P RM -B0034-geneVI) (10-20 fmol per plasmid; typically 1-2 µl in total). Note that the P RM promoter can be replaced by an alternative promoter (e.g., T7) to obtain higher phage titers in the absence of the activator λ cI.
24|
Add 250 µl of SOC medium to the samples and incubate for 1 h at 37 °C at 220 r.p.m. (SI500 incubator). 25| Spread the cells on LB plates supplemented with 25 µg ml −1 chloramphenicol and 50 µg ml −1 kanamycin. Allow them to grow overnight at 37 °C.
26|
The next day, pick a single colony and grow it in 2× TY supplemented with 12.5 µg ml −1 chloramphenicol and 25 µg ml −1 kanamycin at 37 °C at 250 r.p.m. (SI500 incubator) until the OD 600 reaches 0.4-0.6 (mid-exponential phase) and make cells electrocompetent as described by Gonzales et al. 42 .  pause poInt Competent cells are stored at -80 °C. Stored electrocompetent cells can be used for the construction of any phage library.
27|
Transfer 50 µl of the electrocompetent cells to a prechilled 1.5-ml tube on ice and add 1-2 µl of the cloned combinatorial PM library.
28|
Electroporate cells, and immediately add 950 µl of SOC medium and incubate for 1 h at 37 °C at 220 r.p.m. (SI500 incubator).
29|
Estimate the actual phage library by colony-counting serial dilutions (10 −2 and 10 −4 in 2× TY) on LB plates supplemented with ampicillin (Step 20).  crItIcal step Make sure not to lose any library members through low transformation efficiencies. ? trouBlesHootInG 30| Add 3 ml of 2× TY supplemented with 12.5 µg ml −1 chloramphenicol, 25 µg ml −1 kanamycin and 50 µg ml −1 ampicillin to the transformation reaction and grow for 18-20 h at 30 °C at 250 r.p.m. (SI500 incubator). Note that the volume can be adjusted depending on the desired volume of the phage titer.
31|
The next day, centrifuge the sample for 5 min at 5,000g and 4 °C.
32|
Filter-sterilize the phage supernatant (0.22-µm pore size).  pause poInt The phage library can be kept at 4 °C for short-term storage (weeks) or at −20 °C for long-term storage (years).
phage titer analysis • tIMInG 3 d 33| Streak out TG1 cells from a glycerol stock (~1-5 µl) on an M9 minimal medium plate and incubate overnight at 37 °C. Note that TG1 plates can be used for a maximum of 2 weeks when stored at 4 °C.  crItIcal step Use M9 minimal medium plates to select F-pilus-positive TG1 cells.
34|
The next day, pick one to four single isolated colonies from the M9 minimal medium plate and inoculate in 10 ml of 2× TY medium in a 50-ml conical centrifuge tube.
35|
Incubate at 37 °C and 250 r.p.m. (SI500 incubator) until the OD 600 reaches 0.4-0.6 (mid-exponential phase). It typically takes 4-6 h for the culture to reach the desired OD 600 .  crItIcal step Do not let the cells grow into stationary phase, as TG1 cells tend to lose the F episome, and this lowers the overall infection rate.
36|
In the meantime, prepare serial dilutions (10 −2 , 10 −4 , 10 −6 , 10 −8 in 2× TY) of the phage library in sterile 1.5-ml tubes. Phage stocks are diluted before infection to ensure that each cell is infected by only one phage particle (the number of colonies on plates equals the number of phage particles).
37|
Add 100 µl of the phage dilutions to 900 µl of TG1 cells in a sterile microcentrifuge tube. Mix gently and incubate the samples for 1 h at 37 °C without shaking. Plate 100 µl of cell suspension on prewarmed LB plates supplemented with 100 µg ml −1 ampicillin and incubate overnight at 37 °C.
38|
The next day, count the number of colonies and calculate the phage titer (equation (1)). Ideally, use the plates containing 20-400 colonies. Note that the 100-fold dilution (Step 37) has to be taken into consideration.
Phage titer per ml dilution factor 100 number of colonies on plate = × × construction of accessory and reporter plasmids • tIMInG 2 weeks 39| Order user-specific forward and reverse primers to replace the P RM promoter on the AP plasmid (pJPC12-∆PS-P RM -B0034-geneVI) with a different promoter or inducible input. For vector amplification, use primers B0034-gVI-F and gVI-R, which bind upstream and downstream of P RM (supplementary table 2 ). For insert amplification, make sure to add a 15-to 25-bp overlap for assembly. Optional: clone the same inducible input into pJPC12-∆PS-mCherry-P R /P RM -GFP to obtain a reporter for the functional characterization of selected proteins. Use primers GFP-F and mCherry-R for vector amplification (supplementary table 2).
40|
Clone the AP and RPs as described in Steps 3-10. Use sequencing primers pJPC12-F and/or pJPC12-R for gene VI constructs and pJPC12-F2 for reporters (table 1) .
preparation of host cells for directed evolution • tIMInG 3 d 41| Transform 50 µl of competent TG1 cells with equal mole amounts of HP M13KO7-∆PS-∆geneIII-∆geneVI and the cloned AP (10-20 fmol per plasmid; typically 1-2 µl in total).  crItIcal step Always use an E. coli strain that contains the F-factor needed for M13 phage infection.
42| Add 250 µl of SOC medium to the sample and incubate for 1 h at 37 °C at 220 r.p.m. (SI500 incubator).
43|
Spread the cells on LB plates supplemented with 25 µg ml −1 chloramphenicol and 50 µg ml −1 kanamycin and allow the cells to grow overnight at 37 °C.
44|
The next day, pick a single colony and allow the cells to grow in 2 ml of 2× TY supplemented with kanamycin and chloramphenicol for 4-6 h at 37 °C at 250 r.p.m. (SI500 incubator) until the cells reach the late-exponential phase.
45| (Optional) Make glycerol stock (Reagent Setup).
 pause poInt The glycerol stocks can be stored at −80 °C for up to several years.
46|
Make serial dilutions of the cell suspension (e.g., 10 −6 or 10 −8 in M9 medium) and spread the diluted cells on an M9 minimal medium plate supplemented with 25 µg ml −1 chloramphenicol and 50 µg ml −1 kanamycin. These conditions promote phage infectability by maintaining F′ pili.
47|
Incubate the plates for 30-48 h at 37 °C. Note that bacteria grow much slower on minimal media than on rich media. This plate is used as a source of fresh colonies for selection experiments and can be used for up to 2 weeks when stored at 4 °C.
phage-assisted batch selection • tIMInG 2 weeks 48| Inoculate 10-20 ml of 2× TY containing 12.5 µg ml −1 chloramphenicol and 12.5 µg ml −1 kanamycin with one to four colonies from the prepared M9 plate (Step 47) in a 50-ml tube (Fig. 6) . 
49|
64|
The next day, pick single colonies and allow them to grow in 1 ml of 2× TY supplemented with 5 µg ml −1 chloramphenicol and 5 µg ml −1 carbenicillin for 4-6 h at 37 °C at 250 r.p.m. (SI500 incubator). Analyze at least three replicates per transformation.
65|
Measure the OD 600 of each replicate (150 µl) with the Tecan Infinite M200 plate reader.
66|
Dilute cultures in 2× TY supplemented with 5 µg ml −1 chloramphenicol and 5 µg ml −1 carbenicillin to a final OD 600 of 0.01 (150 µl) in a 96-well microplate.
67|
Measure the absorbance at 600 nm (green fluorescence, excitation 485 nm, emission 520 nm; red fluorescence, excitation 585 nm, emission 625 nm) every 10 min with the Infinite M200 plate reader (at 37 °C, shaking between readings) until the cells reach stationary phase.
68|
For data analysis, use fluorescence readings in the mid-exponential phase (OD 600 of 0.2) and correct absorbance and fluorescence against readings of a TG1 culture. Normalize the fluorescence for the number of cells by dividing by the absorbance.
? trouBlesHootInG Troubleshooting advice can be found in table 2. 
antIcIpateD results
The first section of this protocol describes the construction of combinatorial libraries used for subsequent directed evolution experiments. As examples, we describe the construction of two cI opt libraries, each of which contains five randomized positions: library 1 (45S, 46G, 47V, 48G, 55N) and library 2 (45S, 46G, 48G, 49A, 55N). Quality-control sequencing of 10-100 clones of a library may be performed to confirm diversity, depending on the library size and quality control desired. For example, ten individual clones of a constructed library should ideally result in ten different variants (table 3) . 55N ) is selected against P M,5T6T , and library 2 (45S, 46G, 48G, 49A, 55N) is selected against P M,5G6G , with counterselection against wild-type binding. Non-wild-type amino acids are indicated by asterisks, and the amino acid that is not part of the combinatorial library is annotated with "+." Positions 35, 38 and 39 illustrate the amino acid mutations in λ cI used to obtain cI opt and are denoted by a subscript "P" for selected variants (e.g., cI 5G6G,P ).
